---
title: "000153.SZ (000153.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000153.SZ/news.md"
symbol: "000153.SZ"
name: "000153.SZ"
parent: "https://longbridge.com/en/quote/000153.SZ.md"
datetime: "2026-05-20T21:18:49.707Z"
locales:
  - [en](https://longbridge.com/en/quote/000153.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000153.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000153.SZ/news.md)
---

# 000153.SZ (000153.SZ) — Related News

### [FENGYUAN PHARMACEUTICAL's subsidiary has received the approval notice for the listing application of fumaric acid voronol](https://longbridge.com/en/news/286070402.md)
*2026-05-12T09:32:02.000Z*
> FENGYUAN PHARMACEUTICAL's wholly-owned subsidiary, Bengbu FENGYUAN Tushan Pharmaceutical Co., Ltd., recently received th

### [FENGYUAN PHARMACEUTICAL: Compound Polyethylene Glycol Electrolyte Powder Obtains Drug Registration Certificate](https://longbridge.com/en/news/285513592.md)
*2026-05-07T08:42:27.000Z*
> FENGYUAN PHARMACEUTICAL (000153) announced on May 7th that the company recently obtained the registration certificate fo

### [](https://longbridge.com/en/news/282117955.md)
*2026-04-09T01:38:25.000Z*
> The A-share generic drug concept rose in early trading, with HPGC up over 8%, and Luoxin Pharmaceutical, NEPTUNUS, FENGY

### [FENGYUAN PHARMACEUTICAL obtained the drug registration certificate for Compound Sodium Acetate Ringer's Injection](https://longbridge.com/en/news/277595985.md)
*2026-03-03T09:35:04.000Z*
> FENGYUAN PHARMACEUTICAL announced that the company has obtained the drug registration certificate for Compound Sodium Ac

### [FENGYUAN PHARMACEUTICAL: Increased investment of 53 million yuan to Hefei Hongfeng Equity Investment Fund Center](https://longbridge.com/en/news/270979851.md)
*2025-12-29T10:08:52.000Z*
> FENGYUAN PHARMACEUTICAL announced that the company plans to increase its capital by RMB 53 million to Hefei Hongfeng Equ

### [FENGYUAN PHARMACEUTICAL: Shareholders have pledged a total of 45.74 million company shares](https://longbridge.com/en/news/267483344.md)
*2025-11-26T08:57:51.000Z*
> FENGYUAN PHARMACEUTICAL announced that its shareholder Anhui Wuwei Pharmaceutical Factory pledged 31.62 million company 

### [FENGYUAN PHARMACEUTICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 100 million yuan, a year-on-year decrease of 31.92%](https://longbridge.com/en/news/262455354.md)
*2025-10-23T13:36:02.000Z*
> According to the Zhitong Finance APP, FENGYUAN PHARMACEUTICAL released its third-quarter report for 2025. In the first t

### [Zhitong A-share lock-up release overview | October 13](https://longbridge.com/en/news/260808467.md)
*2025-10-13T01:01:04.000Z*
> On October 13th, 29 listed companies will have their restricted shares unlocked, with a total market value of approximat

### [FENGYUAN PHARMACEUTICAL: The transfer of part of the company's shares by the controlling shareholder and its concerted parties has been completed](https://longbridge.com/en/news/255750595.md)
*2025-09-03T09:16:11.000Z*
> FENGYUAN PHARMACEUTICAL announced that its controlling shareholder, FENGYUAN Group, and its concerted party, Ma'anshan F